Generics bulletin-i provides intelligent information on the move for the global generic and biosimilar medicines industries. Subscribers benefit from weekly commercial intelligence about business opportunities, enabling them to make better decisions faster.
They also get access to more than 120 back issues in a searchable archive. This offers an invaluable resource for researching market opportunities, benchmarking competitive strengths, evaluating regulatory changes and assessing product developments.
With subscribers in over 50 countries, Generics bulletin is read by senior executives engaged in developing, licensing, authorising, manufacturing, distributing and marketing generic and biosimilar medicines; developing and producing active pharmaceutical ingredients (APIs); litigating patent and other intellectual property disputes; or supplying goods and services to the generic and bisosimilar medicines industries.
Published on Fridays, Generics bulletin appears 46-times a year – weekly in most months, but less frequently in January, July, August and December.
1 month at £94.99.
The subscription will include the current issue if you do not already own it and subsequently published future issues. Payment will be charged to your app store account at confirmation of purchase. This subscription will automatically renew unless auto-renew is turned off at least 24-hours before the end of the current period. Your account will be charged for renewal within 24-hours prior to the end of the current period. The cost of the renewal will match the initial subscription price.
You may turn off auto-renewing subscriptions by going to your user’s Account Settings after purchase. No cancellation of the current subscription is allowed during your active subscription period.